The global intravenous catheters market is experiencing significant growth, driven by an increase in hospitalizations and surgical procedures, particularly in intensive care units (ICUs) and oncology. The higher adoption of peripherally inserted central catheters (PICCs) and midline catheters, along with a growing focus on infection control, is also driving demand for coated and antimicrobial catheters.
However, the risk of catheter-associated infections and complications is hindering market growth. Currently, North America holds the largest share of the global market, largely due to its high prevalence rates and the burden of chronic diseases. In contrast, the Asia Pacific region is rapidly emerging as the fastest-growing market, supported by a developing healthcare infrastructure and a large patient population.
Major companies in the market, such as Medtronic Plc, Abbott Laboratories, and Boston Scientific Corp, are actively pursuing product innovation, forming partnerships, and exploring new markets. As the demand for intravenous catheters increases and new advanced catheters are developed, a noticeable growth rate in the global intravenous catheter market is expected. This will likely lead to reduced catheter costs, improved effectiveness, and ultimately enhanced patient outcomes worldwide.
You can easily get a sample PDF of the report – https://www.businessmarketinsights.com/sample/BMIPUB00031921
Intravenous Catheters Market Segmentation Analysis
Key segments that contributed to the derivation of the Intravenous Catheters market analysis are product, coating type, lumen, and end user.
- By product, intravenous catheters market is segmented into peripheral catheter, central catheter, PICC catheter, and others. The peripheral catheter segment dominated the market in 2024.
- By coating type, intravenous catheters market is segmented into coated catheter and uncoated catheter. The coated catheter segment dominated the market in 2024.
- By lumen, intravenous catheters market is segmented into single-lumen and multi-lumen. The multi-lumen segment dominated the market in 2024.
- By end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, diagnostic imaging centers, and others. The hospitals & clinics segment held the largest share of the market in 2024.
Intravenous Catheters Market Drivers and Opportunities:
Higher Adoption of Peripherally Inserted Central Catheters (PICCs) and Midline Catheters Driving Intravenous Catheters Market
The growing use of Peripherally Inserted Central Catheters (PICCs) and midline catheters is becoming increasingly important in advancing the intravenous (IV) catheter market. PICCs, in particular, are valuable for providing long-term IV therapy that lasts more than one week. This increased demand is largely due to the rise in chronic diseases such as cancer, which often require chemotherapy and other infusions that extend beyond a week.
Additionally, central venous catheters (CVCs), including PICCs, present a lower risk of bloodstream infections than other CVC types. Since PICCs are commonly inserted in the arm, they may provide a more comfortable option for patients undergoing prolonged infusions. The trend towards outpatient and home care has also made PICCs more appealing, as they align with patient preferences and can be utilized in non-traditional care settings. This shift is likely influenced by various factors, including changes in patient preferences and the post-COVID landscape, which has encouraged care to move back into homes and away from hospitals.
Midline catheters are expected to further support this market by fulfilling a unique role between short peripheral IVs and PICCs. This segment caters to therapies that last approximately 1 to 4 weeks, making midline catheters particularly suitable for prolonged antibiotic treatments. As central venous catheters, midlines reduce the need for frequent catheter changes compared to short peripheral IVs, enhancing patient comfort, minimizing supply usage, and often eliminating the necessity to replace short peripheral IVs altogether.
Development of Longer-dwell, Low Maintenance PICCs for Outpatient and Home Care Use
The transition to outpatient and home care presents a significant opportunity for the intravenous catheter market, particularly for longer-dwell, low-maintenance peripheral inserted central catheters (PICCs). Healthcare systems are moving away from hospital settings to reduce costs, driving demand for devices that provide safe and reliable venous access for weeks or even months in non-hospital environments. This shift has spurred ongoing innovation in catheter materials and designs.
Manufacturers of PICCs are now developing a new generation of catheters featuring antimicrobial coatings to minimize the risk of infection. These innovations utilize a unique polyurethane and hydrogel composite that enhances durability and biocompatibility, thereby decreasing the likelihood of complications such as thrombosis and occlusion.
Ensuring patient safety and comfort, especially in home care settings, where medical professionals provide less oversight, remains a challenge. There is a considerable opportunity to design catheters that offer long-term access while reducing the workload for patients and visiting nurses. This could include the implementation of valve PICCs, which maintain a closed system and eliminate the need for heparin flushing. Such advancements may help lower the frequency of required maintenance.
Intravenous Catheters Market News and Key Development:
The intravenous catheters market y
- FDA approved BD CentroVena Central Venous Catheter (CVC) with CentroVena One Insertion System. This approval expands BD’s offerings in acute central venous access, designed for short-term use (less than 30 days) to administer fluids, blood products, drugs, and for blood withdrawal and central venous pressure monitoring, including power injection capabilities. (Source: Becton Dickinson and Co, Press Release, April 2025)
- B. Braun Medical received FDA clearance for its Introcan Safety 2 Deep Access IV Catheter. This new device is designed to improve safety and patient comfort by providing deeper venous access while incorporating safety features to reduce needlestick injuries and blood exposure to healthcare providers. (Source: B Braun SE, Press Release, October 2024)
Get Premium Research Report at: https://www.businessmarketinsights.com/buy/BMIPUB00031921
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
- If you have any questions about this report or would like further information, please contact us:
- Contact person: Ankit Mathur
- Email: sales@businessmarketinsights.com
- Phone: +16467917070
